An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug ...

Sanford – UK DRI at the University of Cambridge Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader application in ...

Promising 'First' in ... Alzheimer's disease and other kinds of dementia, a new study suggests that getting the diagnosis needed to access these new treatments may ... Genetic Link Between ...

Innovators from across the UK will be offered the chance to test their ideas in the city. The most promising will be ...

A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

Alzheimer's is a brain disease that causes memory loss and thinking problems. It gets worse over time and is the most common ...

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and ...

New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction ...

Congress must pass and fully fund the BOLD Reauthorization Act to continue strengthening the public health response to ...

Researchers have hailed a promising breakthrough in the development ... this unique approach could help address the growing ...